BDBM447722 (R)-N-(1-cyanopyrrolidin-3-yl)-6- (3,5-dimethylisoxazol-4-yl)-N- methyl-1H-indole-2-carboxamide::US10689345, Example 262::US11066365, Example 262

SMILES CN([C@@H]1CCN(C1)C#N)C(=O)c1cc2ccc(cc2[nH]1)-c1c(C)noc1C

InChI Key InChIKey=ZVTXOPLNDAQZDV-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 447722   

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mission Therapeutics

US Patent
LigandPNGBDBM447722((R)-N-(1-cyanopyrrolidin-3-yl)-6- (3,5-dimethyliso...)
Affinity DataIC50: 100nMAssay Description:USP30 Biochemical Fluorescence Intensity Kinetic Assay.Reactions were performed in duplicate in black 384 well plates (small volume, Greiner 784076) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mission Therapeutics

US Patent
LigandPNGBDBM447722((R)-N-(1-cyanopyrrolidin-3-yl)-6- (3,5-dimethyliso...)
Affinity DataIC50: 100nMAssay Description:USP30 biochemical fluorescence intensity IC50 assay Dilution plates were prepared at 21 times the final concentration (2100 μM for a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2021
Entry Details
US Patent